Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Mar 20, 2026 0

Researchers at Johns Hopkins Kimmel Cancer Center have introduced a groundbreaking advancement in liquid biopsy technology, demonstrating that measuring the…

Read More
Stem Cell & Regenerative Medicine

Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Progression via Liquid Condensates

Dwi Wanna Mar 19, 2026 0

In a significant advancement for the field of molecular oncology, a collaborative study led by investigators at the Johns Hopkins…

Read More

Posts pagination

1 2 3
Innovative targeted protein degradation strategy suppresses tumor growthScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic InterruptionBreakthrough in PFAS Degradation Scientists Identify Hydrogen Radicals as Key to Destroying Forever Chemicals Using UV Light
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ